10x Genomics jumps after forecasting Q4 revenue above estimates
ReutersNov 7, 2025 10:55 AM
Shares of life sciences tech firm 10x Genomics TXG.O rise 11.6% to $14.51 premarket
10x Genomics expects Q4 revenue to be in the range of $154 million to $158 million, compared with analysts' estimate of $154.1 million - LSEG data
Company posts Q3 revenue of $149 million, above estimate of $142.5 million
As of last close, stock down 9.5% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Bitcoin Cash Unveiled: Why Did BCH Price Surpass BTC? Can it Soar to $1,000 in the Future?
Bitcoin Cash (BCH) is poised for a 2025 resurgence, fueled by marginal fundamental improvements, market rotation, and speculative interest. Significant whale capital inflows are also expected to drive this rally. However, while BCH may outperform Bitcoin (BTC) in the near term, a sustained breakthroTradingKey
Fri, Dec 5
GameStop: From Epic Short Squeeze to Q3 Earnings, Where Does This Meme Stock Go Next?
TradingKey – GameStop 2021 epic short squeeze to today’s earnings recovery, this legacy game retailer is betting on collectibles and geek-culture transformation while, before its Q3 report, options flows and sentiment once again push Gamestop’s meme premium into spotlight.TradingKey
Fri, Dec 5
After the Crypto Crash, Is an Altcoin Season Looming Post-Liquidation?
TradingKey - The crypto market remains unsettled two months after the October 10 liquidation wave, one of its largest ever. Bitcoin's price has erased all its year-to-date gains, quieting predictions of a 2025 bull run. Amid Bitcoin's struggles and weakening year-end liquidity, calls for an altcoinTradingKey
Fri, Dec 5
Rivian Stock Analysis: Q3 Earnings Exceed Expectations – Is Now the Time to Buy RIVN Stock?
Is Rivian still a good investment now? Can Rivian's stock reclaim its previous highs?TradingKey
Thu, Dec 4
Why Did Strategy's Stock Price Plummet? Can MSTR Reach $1,000?
MicroStrategy (MSTR) stock, despite pressures from Bitcoin volatility and its weak core business, represents the most leveraged investment in a Bitcoin bull market. The company's stock path to $1,000 largely depends on Bitcoin's market performance. Major institutions, including Standard Chartered anTradingKey
Thu, Dec 4
Tradingkey
